 Relmada Therapeutics Inc NASDAQ: RLMD shares are trading higher by 7.2 at 25.01 after the company reported better-than-expected fourth-quarter EPS results. Relmada Therapeutics reported quarterly losses of 1.80 per share which beat the analyst consensus estimate of a loss of 1.83. 